Optimising Visual Acuity Measurement in Macular Degeneration

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Age Related Macular Degeneration
Interventions
DEVICE

Visual acuity and contrast sensitivity measurement

Those subjects who meet the inclusion criteria will undergo the study tests. These measurements will be performed on one eye only. Visual acuity will be quantified using two forms of the MAC chart (MAC 1 and 2) and two forms of a conventional letter design chart (C1 and 2). Contrast sensitivity will be measured using the two forms of the Pelli-Robson chart (CS1 and CS2). The order with which the test charts will be presented, in addition to the charts used (i.e. MAC 1 or 2, C1 or 2, and CS1 or 2), will be selected at random. Finally, a measurement of eye length will be collected using an IOL Master (Carl-Zeiss Meditec, USA).

Trial Locations (1)

Unknown

Moorfields Eye Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

Moorfields Eye Hospital NHS Foundation Trust

OTHER

NCT04920071 - Optimising Visual Acuity Measurement in Macular Degeneration | Biotech Hunter | Biotech Hunter